CSPC Pharmaceutical Group Limited (HKG: 1093)
Hong Kong
· Delayed Price · Currency is HKD
5.25
-0.09 (-1.69%)
Nov 13, 2024, 4:08 PM HKT
CSPC Pharmaceutical Group Revenue
CSPC Pharmaceutical Group had revenue of 7.30B CNY in the quarter ending June 30, 2024, a decrease of -9.04%. This brings the company's revenue in the last twelve months to 31.65B, up 0.79% year-over-year. In the year 2023, CSPC Pharmaceutical Group had annual revenue of 31.45B with 1.66% growth.
Revenue (ttm)
31.65B CNY
Revenue Growth
+0.79%
P/S Ratio
1.81
Revenue / Employee
1.35M CNY
Employees
23,500
Market Cap
59.79B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 31.45B | 513.21M | 1.66% |
Dec 31, 2022 | 30.94B | 3.07B | 11.02% |
Dec 31, 2021 | 27.87B | 2.92B | 11.73% |
Dec 31, 2020 | 24.94B | 2.84B | 12.84% |
Dec 31, 2019 | 22.10B | 4.39B | 24.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCSPC Pharmaceutical Group News
- 15 days ago - CSPC Pharmaceutical Group Limited goes ex dividend tomorrow - Seeking Alpha
- 5 weeks ago - AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline - Benzinga
- 5 weeks ago - Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge - Benzinga
- 5 weeks ago - Crude Oil Gains Over 3%; Scholar Rock Shares Spike Higher - Benzinga
- 5 weeks ago - US Stocks Open Lower; Dow Tumbles Over 150 Points - Benzinga
- 5 weeks ago - AstraZeneca Inks $1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline - Benzinga